HIV Cure Update: Genetically Engineered Proteins Could Remove 85 Percent of HIV-Infected Cells in Laboratory Setting

A new study confirmed the pptency of the new ImmTAV in combination with successful antiretroviral therapy and donated CD8+ T-cells in removing up to 85 percent of HIV-infected cells.